Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions

Journal of Virology

Volumn 77, Issue 16, 2003, Pages 8882-8892

  Schilling, Ralf ^a   Ijaz, Samreen ^a   Davidoff, Michail ^b   Lee, Jia Yee ^c   Locarnini, Stephen ^c   Williams, Roger ^a   Naoumov, Nikolai V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Vic Infect Dis Ref Laboratory   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G;

AMINO ACID SUBSTITUTION; ANTIBODY TITER; ARTICLE; CELL COMPARTMENTALIZATION; ENDOCYTOSIS; GENETIC TRANSFECTION; HEPATITIS B; HUMAN; HUMAN CELL; INTERNALIZATION; LIVER CELL; PRIORITY JOURNAL; PROPHYLAXIS; VIRION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

BASE SEQUENCE; DNA PRIMERS; ENDOCYTOSIS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; IMMUNOGLOBULINS; TUMOR CELLS, CULTURED; VIRION; VIRUS REPLICATION;

EID: 0042208197     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.16.8882-8892.2003     Document Type: Article

References (30)

1. Blumberg, R. S., T. Koss, C. M. Story, D. Barisani, J. Polischuk, A. Lipin, L. Pablo, R. Green, and N. E. Simister. 1995. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J. Clin. Investig. 95:2397-2402.
2. Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
3. Carman, W. F., C. Trautwein, F. J. van Deursen, K. Colman, E. Dornan, G. McIntyre, J. Walters, V. Kliem, R. Muller, H. C. Thomas, and M. P. Manns. 1996. Hepatitis B envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 24:489-493.
4. Carman, W. F., A. Owsianka, L. A. Wallace, B. C. Dow, and D. J. Mutimer. 1999. Antigenic characterisation of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J. Hepatol. 31:195-201.
5. Cooreman, M. P., M. H. van Roosmalen, R. te Morsche, C. M. Sunnen, E. M. de Ven, J. B. Jansen, G. N. Tytgat, P. L. de Wit, and W. P. Paulij. 1999. Characterization of the reactivity pattern of murine antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology 30:1287-1292.
6. Ghany, M. G., B. Ayola, F. G. Villamil, R. G. Gish, S. Rojter, J. M. Vierling, and A. S. Lok. 1998. Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27:213-222.
7. Ghetie, V., and E. S. Ward. 2000. Multiple roles for the major histocompatibility complex class I-related receptor FcRn. Annu. Rev. Immunol. 18:739-766.
8. Ijaz, S., F. Torre, R. S. Tedder, R. Williams, and N. V. Naoumov. 2001. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. J. Med. Virol. 63:210-216.
9. Junghans, R. P., and C. L. Anderson. 1996. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93:5512-5516.
10. Kalinina, T., A. Riu, L. Fischer, H. Will, and M. Sterneck. 2001. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 34: 385-394.
11. Koscec, M., E. Koren, M. Wolfson-Reichlin, R. D. Fugate, E. Trieu, I. N. Targoff, and M. Reichlin. 1997. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J. Immunol. 159:2033-2041.
12. Ladner, S. K., M. J. Otto, C. S. Barker, K. Zaifert, G. H. Wang, J. T. Guo, C. Seeger, and R. W. King. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblasma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1715-1720.
13. Lee, J. Y., J. Culvenor, P. Angus, R. Smallwood, A. Nicoll, and S. A. Locarnini. 2001. Detection of duck hepatitis B virus replicative marker in primary cultures of bile duct epithelial cells. J. Virol. 75:7651-7661.
14. Lok, A. V., U. Akarca, and S. Greene. 1994. Mutations in the pre-core region of hepatitis B virus serve to enhance the secondary structure of the pregenome encapsidation signal. Proc. Natl. Acad. Sci. USA 91:4077-4081.
15. Marusawa, H., S. Uemoto, M. Hijikata, Y. Ueda, K. Tanaka, K. Shimotohno, and T. Chiba. 2000. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31:488-495.
16. Mazanec, M. B., C. S. Kaetzel, M. E. Lamm, D. Fletcher, and J. G. Nedrud. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89:6901-6905.
17. Meliconi, R., M. V. Stancari, M. Garagnani, M. Baraldini, G. F. Stefanini, F. Miglio, and G. Gasbarrini. 1983. Hepatocyte membrane-bound IgG and circulating liver-specific autoantibodies in chronic liver disease: relation to hepatitis B virus serum markers and liver histology. Hepatology 3:155-161.
18. Mitrenga, D., W. Arnold, O. Muller, and H. von Mayersbach. 1975. The fate of injected human IgG in the mouse liver. Cell Tissue Res. 156:359-376.
19. Naumov, N. V., M. Mondelli, G. J. Alexander, R. S. Tedder, A. L. Eddleston, and R. Williams. 1984. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte toxicity in patients with chronic hepatitis B virus infection. Hepatology 4:63-68.
20. Naoumov, N. V., A. R. Lopes, P. Burra, L. Caccamo, R. M. Immolo, R. A. deMan, M. Bassedine, J. G. O'Grady, B. C. Portmann, G. Anschuetz, C. A. Barret, R. Williams, and M. Atkins. 2001. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J. Hepatol. 34:888-894.
21. Pas, S. D., E. Fries, R. A. De Man, A. D. Osterhaus, and H. G. Niesters. 2000. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J. Clin. Microbiol. 38: 2897-2901.
22. Protzer-Knolle, U., U. Naumann, R. Bartenschlager, T. Berg, U. Hopf, K. H. Meyer zum Buschenfelde, P. Neuhaus, and G. Gerken. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254-263.
23. Rizzetto, M., M. G. Canese, S. Arico, O. Crivelli, C. Trepo, F. Bonino, and G. Verme. 1977. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18:997-1003.
24. Samuel, D., R. Muller, G. Alexander, L. Fassati, B. Ducot, J. P. Benhamou, and H. Bismuth. 1993. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 329:1842-1847.
25. Terrault, N. A., S. Zhou, C. Combs, J. A. Hahn, J. R. Lake, J. P. Roberts, N. L. Ascher, and T. L. Wright. 1996. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 24:1327-1333.
26. Thomas, H. C., and W. F. Carman. 1994. Envelope and precore/core variants of hepatitis B virus. Gastroenterol. Clin. N. Am. 23:499-514.
27. Waters, J. A., M. Kennedy, P. Voet, P. Hauser, J. Petre, W. Carman, and H. C. Thomas. 1992. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Investig. 90: 2543-2547.
28. Yanase, K., R. M. Smith, A. Pucetti, L. Jarett, and M. P. Madaio. 1997. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J. Clin. Investig. 100:25-31.
29. Zhu, X., G. Meng, B. L. Dickinson, X. Li, E. Mizogushi, L. Miao, Y. Wang, C. Robert, B. Wu, P. D. Smith, W. I. Lencer, and R. S. Blumberg. 2001. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol. 166: 3266-3276.
30. zu Putlitz, J., A. Skerra, and J. R. Wands. 1999. Intracellular expression of a cloned antibody fragment interferes with hepatitis B virus surface antigen secretion. Biochem. Biophys. Res. Commun. 255:785-791.